Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can touch and sound boost mirror therapy for stroke patients?

NCT ID NCT07426354

Symptom relief Sponsor: Asia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding touch and sound feedback to standard mirror therapy can improve arm function in stroke survivors with arm weakness. Eighty-four participants will be split into three groups: one gets the enhanced therapy, one gets digital mirror feedback only, and one uses a traditional mirror box. They will attend 20 therapy sessions, and their arm movement and brain activity will be measured before, after, and at a one-month follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multimodal Augmented Mirror Therapy (MAF-MT) – a behavioral therapy combining digital mirror visual feedback with added touch and sound cues
What this could lead to
If it works, this could point toward a more effective, low-cost rehabilitation method to improve arm movement and daily function after stroke.
What could go wrong
This is an early-stage, single-site study with only 84 participants. The added sensory feedback may not provide meaningful improvement over standard mirror therapy, and results may not apply to all stroke survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 3 months post-onset of a unilateral stroke * Age between 20 and 85 years * An initial Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score between 18 and 56 * Ability to follow study instructions, as determined by a Montreal Cognitive Assessment (MoCA) score ≥ 18 * No concurrent participation in other neurorehabilitation studies or drug clinical trials Exclusion Criteria: * Severe neglect, as measured by the line bisection test * Uncontrolled major medical conditions, such as uncontrolled hypertension or heart failure, or concomitant neurological conditions, for example, dementia, Parkinson's disease, brain tumors, or other brain conditions * Severe pain, swelling, spasticity or contractures in affected arms that prevent movement practice and assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiparesis after stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiparesis after stroke Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taipei Tzu Chi Hospital

    New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.